Research is being conducted on targeted medications for esophageal cancer, with potential therapeutic targets identified. Some studies focus on specific aspects of the disease, such as stage 4 esophageal cancer or squamous cell carcinoma, while others explore new approaches like gene editing or targeted therapy. Various institutions and publications are reporting on these developments, suggesting ongoing efforts to improve treatment options for esophageal cancer.